Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.01 - $4.19 $43,645 - $60,755
-14,500 Reduced 16.78%
71,900 $301,000
Q2 2024

Aug 14, 2024

SELL
$2.22 - $3.05 $92,352 - $126,879
-41,600 Reduced 32.5%
86,400 $263,000
Q1 2024

May 15, 2024

BUY
$2.35 - $3.59 $136,065 - $207,861
57,900 Added 82.6%
128,000 $314,000
Q4 2023

Feb 14, 2024

BUY
$1.72 - $3.8 $54,696 - $120,840
31,800 Added 83.03%
70,100 $262,000
Q3 2023

Nov 14, 2023

SELL
$1.93 - $3.26 $54,040 - $91,280
-28,000 Reduced 42.23%
38,300 $74,000
Q2 2023

Aug 14, 2023

BUY
$0.83 - $3.1 $32,204 - $120,280
38,800 Added 141.09%
66,300 $149,000
Q1 2023

May 15, 2023

BUY
$0.65 - $1.89 $17,810 - $51,786
27,400 Added 27400.0%
27,500 $37,000
Q4 2022

Feb 14, 2023

BUY
$0.63 - $1.36 $63 - $136
100 New
100 $0

Others Institutions Holding DHC

About DIVERSIFIED HEALTHCARE TRUST


  • Ticker DHC
  • Exchange NASDAQ
  • Sector Real Estate
  • Industry REIT—Healthcare Facilities
  • Shares Outstandng 239,123,008
  • Market Cap $528M
  • Description
  • DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
More about DHC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.